Zingo Offers Pain Relief During Child Injections (HealthDay)

HealthDay - FRIDAY, Aug. 17 (HealthDay News) -- The pain-relieving drug Zingo
(lidocaine hydrochloride) has been approved by the U.S. Food and Drug
Administration for children aged 3 to 18 who have "venous access"
procedures such as IV insertions or blood draws, maker Anesiva Inc. said
Friday.

Source: http://rss.news.yahoo.com